November 2007 Issue of MMM

November 2007 Issue of MMM

November 2007

Editor's Desk

A new-found exuberance

There hasn't been much good news coming out of Pfizer in the past couple of years. Efforts to replace anticipated losses from the looming patent ...

Features

Force in the Field

Less than a year after declaring it would cut one-fifth of its sales force, Pfizer has come out on top in a study of the ...

Teaching Doctors to Fish

Scott A. Kale, Robert L. Barkin and Peggy Moyer discuss how sales reps oftentimes take the wrong approach in detailing their brands to doctors. The ...

Mixed Fortunes

Laboratory journals posted a 7% hike, while five of eight specialty markets posted moderate gains. PERQ/HCI's Eugene M. May reports on the biggest specialty advertisers ...

Headliner: Gary Stiles of Wyeth

Gary Stiles is under pressure.

Antidote

Antidote

I think it's time I devoted a column to a phenomenon known as forced substitution.

In Focus

Sausage factory passes palatable FDA bill

The eleventh-hour passage of the FDA Amendments Act of 2007 was a white-knuckle ride for the pharmaceutical and advertising industry lobbies, but by and large, ...

Med Ed Report

CME czar brings considerable skills, reputation to Pfizer

Pfizer, in the midst of revamping its CME department, scored a coup with the recent hiring of Maureen Doyle-Scharff, MBA, as director, medical education, US ...

New policy targets them, MECCs charge

With a two-year countdown ticking until a new med-ed policy takes effect, for-profit providers were taking stock of how they can comply.

Sermo adds CME to its offerings

Online physician community Sermo will add CME to its interactive offerings, Dr. Daniel Palestrant, founder and CEO, told MM&M.

Researchers find difficulty recruiting CME speakers

Two researchers have found it's getting harder to recruit speakers for CME programs.

AHECME hires director of oncology grant development

Academy for Healthcare Education (AHECME) has hired Linda Ramos as director of oncology grant development.

Wyeth, Boston University win awards from ACME

Wyeth and Boston University have won the 2008 award for most outstanding industry supported CME activity from the Alliance for CME.

Professional Media

Pfizer, CDM clean up at Doctors' Choice

Professional ads for Pfizer's Chantix and Organon's NuvaRing were the year's top-rated as judged by physicians in the Association of Medical Media's fifth annual Doctors' ...

Google to offer viewership data

Google plans to offer advertisers more than interactive data.

DeSilva + Phillips summit focuses on publishers

The DeSilva + Phillips Healthcare Media M&A Summit focused heavily on how publishers are leveraging their offline properties online.

Clinician Reviews is relaunching

Quadrant Healthcom's Clinician Reviews is re-launching in January with a tabloid format.

FDA launches Drug Safety Newsletter

The FDA has launched Drug Safety Newsletter, a quarterly digest of post-marketing drug safety reviews, important emerging drug safety issues and recently approved drugs for ...

PLoS paper says Zoloft literature ghostwritten

A paper that ran in PLoS said between 18% and 40% of the medical literature on sertaline (Zoloft) that was published in medical journals between ...

Partner Forum

Facing up to pharmas' social anxiety

Everybody's talking about social media as the next marketing channel for pharmas, but when will it materialize, and how deep will companies go?

E-marketing

Web Watch

Consumer-driven healthcare (CDHC) is a term that is relatively new and still being defined.

Hearst Magazines takes on wellness with RealAge

San Diego-based health and wellness Web site RealAge.com has been acquired by Hearst Magazines, a division of Hearst Corporation. Financial terms of the deal were ...

Filmmakers try their hand at FluFlix

Novartis Vaccines and Diagnostics' contest soliciting user-generated content (UGC) from Web-savvy filmmakers continued to gain momentum during the month of October.

Direct Marketing

Goldberg to lead Pfizer account at G2

Direct marketing and digital agency, G2 Direct & Digital, has named Dr. Daniel Goldberg as VP, group account director, to lead its Pfizer account for ...

FDA issues warning letter over mailer

The FDA has issued Eli Lilly a warning letter over effectiveness claims the company made in a 2005 promotional mailer to physicians for its blockbuster ...

AZ boosts training with simulations

AstraZeneca has been using sales simulations to help bolster rep training for real product details behind its new asthma drug Symbicort.

Smith named SVP of sales at Sepracor

Jay Smith was named SVP of sales at Sepracor.

Rowsom joins MediZine as EVP, interactive marketing

Michael Rowsom has joined MediZine as EVP, interactive marketing.

InfoMedics adds new members to its team

InfoMedics announced the addition of two new hires—Clark Green, VP of US pharmaceutical sales and Nathan Tsakiris, director of product development.

Pharmagistics, Arista enter deal

Publicis Healthcare direct marketing solutions companies Pharmagistics and Arista have entered a deal to provide inside sales coverage during vacancies to an undisclosed client.

DTC Report

Olympian Retton hawks knee devices

Mary Lou Retton is returning to TV advertising for device manufacturer Biomet's Oxford Partial Knee System.

Chantix DTC ads star tortoise and hare

Pfizer is advising smokers that quitting is "not a challenge for sprinters" in its consumer advertising campaign for smoking cessation drug Chantix.

Pharma dodges bullet on FDA Amendments Act of 2007

Pharmas dodged a bullet as President George W. Bush signed an FDA Amendments Act of 2007 stripped of several restrictions on consumer advertising on Sept. ...

Taurel says Lilly will boost Cymbalta advertising

Lilly chief Sidney Taurel told Reuters the company would boost consumer advertising for Cymbalta as the firm seeks additional indications on the drug, including chronic ...

Pharma spend on Spanish language TV up

Pharma spending on Spanish language network TV jumped 46.4% year-on-year for the first quarter of 2007 to $8.2 million, according to Nielsen Monitor-Plus data cited ...

Poll reveals adults ask for advertised drugs

A poll of Pennsylvania adults by the Pennsylvania Medical Society found that nearly 45% of participants had asked their doctor about a drug or medical ...

Public Relations

PR View by Lynn Hanessian

Keeping up with new communication technologies and online trends is a critical bar for entry in our business.

Sanofi corrals stars for cancer awareness effort

Sanofi-Aventis is partnering with four major cancer patient groups and Wachovia to produce a star-studded series of events aimed at raising awareness of women's cancers.

Euro RSCG joins health, consumer PR

Euro RSCG is merging its healthcare PR and US PR arms.

Marketing Research

Vantage Point

Good, old-fashioned pharmaceutical marketing research--comparing Product A and Product B--is still being conducted, but the drop in genuinely new molecules has substantially reduced the amount.

Client politics a test of vendor diplomacy skills

Pharma clinical development and product commercialization teams should align around bringing a new drug to market.

Coveted MR prize awarded to Cain

The Pharmaceutical Marketing Research Group (PMRG) presented Brian Cain, executive director, global market research, Schering-Plough, with the RR Fordyce Award at the first annual meeting ...

Washington Insider

As I see it

The FDA's formal public examination of a third class of drugs for the US, between Rx and OTC, sets the stage for a bruising battle ...

Imports act to outsource inspections

Reps. John Dingell (D-MI), Frank Pallone (D-NJ) and Bart Stupak (D-MI), have introduced the "Food and Drug Import Safety Act of 2007" (HR 3610), which ...

OIG will investigate off-label claims

The HHS Office of the Inspector General (OIG) says in its FY 2008 work plan that it will "assess FDA's oversight and review of allowable ...

People trust FDA, unsure if it performs

Results of a new consumer survey on drug safety released by American University's Center for Congressional and Presidential Studies indicate that 82% of Americans surveyed ...

Woodcock steps in at CDER as Galson departs

To help it implement new FDA reform legislation signed into law in September, the Bush administration has shaken up the leadership of the agency's drug ...

Imports act to outsource inspections

Reps. John Dingell (D-MI), Frank Pallone (D-NJ) and Bart Stupak (D-MI), have introduced the "Food and Drug Import Safety Act of 2007" (HR 3610), which ...

People trust FDA, unsure if it performs

Results of a new consumer survey on drug safety released by American University's Center for Congressional and Presidential Studies indicate that 82% of Americans surveyed ...

OIG will investigate off-label claims

The HHS Office of the Inspector General (OIG) says in its FY 2008 work plan that it will "assess FDA's oversight and review of allowable ...

Bradshaw urges generics industry to support user fees

Days after resigning to join the law firm of Hunton & Williams, FDA chief counsel Sheldon Bradshaw took advantage of his sudden freedom to strongly ...

Judge rejects Wyeth and Nycomed's injunction request

A New Jersey federal judge has rejected a request from Wyeth and Nycomed for a preliminary injunction to bar Teva Pharmaceuticals USA and Sun Pharmaceuticals ...

Oliver receives 37 months in jail for accepting bribes

In an action reminiscent of the 1989 generic drug scandal where federal investigators uncovered corrupt FDA reviewers, a judge has sentenced a former FDA consumer ...

Back Talk

Let the games begin!

No, not next summer's Olympic Games scheduled in Beijing from September 6 through the 17, but, the games that are beginning now, which will last ...

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.